AntiCan Cancer Research Results
AntiCan, Anticancer Effect: Click to Expand ⟱
| Source: |
| Type: general indicator |
Anticancer Effect
|
CRC, Colorectal Cancer: Click to Expand ⟱
Colorectal cancer is a broader term that encompasses both colon and rectal cancer.
|
Scientific Papers found: Click to Expand⟱
AntiCan↑, TumCCA↑, Apoptosis↑, eff↑, Bcl-2↓, survivin↓, P21↑, p27/CDKN1B↑, BAX↑, Cyt‑c↑, Casp3↑, PI3K↓, Akt↓, mTOR↓, Hif1a↓, PTEN↑, AMPKα↑, PDH↑, LDHA↓, antiOx↓, ROS↑, AntiCan↑,
| - |
in-vitro, |
GBM, |
U251 |
|
|
|
- |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
in-vitro, |
GBM, |
GL26 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
CRC, |
RKO |
|
|
|
AntiCan↑, eff↑, EPR↑, selectivity↑, ROS↑, Casp↑, Apoptosis↑, DNAdam↑, tumCV↓, eff↑,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Melanoma, |
A2780S |
|
|
|
Bacteria↓, antiOx↑, AntiCan↑, eff↑,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
NRF2↑, TumCCA↑, ROS↑, selectivity↑, *AntiViral↑, *toxicity↝, ETC↓, MMP↓, DNAdam↑, Apoptosis↑, lipid-P↑, other↝, UPR↑, *GRP78/BiP↑, *p‑PERK↑, *cl‑eIF2α↑, *CHOP/DDIT3↑, *JNK↑, Hif1a↓, AntiCan↑, *toxicity↓, eff↑,
| - |
vitro+vivo, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Nor, |
HUVECs |
|
|
|
angioG↓, VEGF↓, TumVol↓, Apoptosis↑, HSP60/HSPD1↓, HTRA↓, survivin↓, XIAP↓, P21↑, *toxicity↓, *neuroP↑, *ROS↓, *COX2/PTGS2↓, *Inflam↓, *cardioP↑, AntiCan↑, ChemoSen↑, ROS↑, MMP↑, Bax:Bcl2↑, TumCG↓,
AntiCan↑, TumCG↓, ROS↑, Apoptosis↑, Endoglin↑, Casp3↑, Casp8↑, Casp9↑, ATG5↑, Beclin-1/ATG6↑, p62↑, PARP↑,
TumCG↓, MAPK↓, TumCCA↑, Apoptosis↑, ROS↑, DNAdam↑, AntiCan↑,
GutMicro↑, HCAR2↑, AntiCan↑, Inflam↓, IL18↑,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
AntiCan↑, chemoPv↑, Apoptosis↑, TumCI↓, Casp↑, p16↑, P21↑, TumCCA↑, ROS↓, eff↓, TumCD↑, TumCG↓, cellSen↑, *ROS↓,
AntiCan↑, GutMicro↝,
| - |
in-vitro, |
CRC, |
SW480 |
|
|
|
- |
in-vitro, |
CRC, |
SW-620 |
|
|
|
*antiOx↑, AntiCan↑, ChemoSen↑, selectivity↑, EMT↓, E-cadherin↑, Vim↓, HMGB1↓, other↝, chemoPv↑,
*Inflam↓, *antiOx↑, AntiCan↑, BioAv↑, Apoptosis↑, angioG↓, Imm↝, ChemoSen↑, chemoP↑,
AntiCan↑, mt-Apoptosis↑, BAX↑, Bcl-2↓, DNAdam↑, TumCCA↑,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
LoVo |
|
|
|
- |
in-vivo, |
CRC, |
HCT116 |
|
|
|
AntiCan↑, eff↑, TumCP↓, TumCCA↓, cycD1/CCND1↓, Pyro↑, Apoptosis↑, cl‑GSDME↑, Bcl-2↓, Cyt‑c↑, Casp9↑, TumCG↓,
PSEN2/PS-2↓, AntiCan↑, Apoptosis↑, Akt↓, ERK↓, *antiOx↑, *Inflam↓, *neuroP↑, *toxicity↓, selectivity↑,
AntiCan↑, p‑Akt↓, TF-Ag↓, *PI3K↓, *AP-1↓, *DNArepair↑, *BioAv↑, *BBB↑, *other↑, *PGE2↓,
| - |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
CRC, |
HT-29 |
|
|
|
AntiCan↑, TumCCA↑, Ki-67↓, PCNA↓,
AntiCan↑, TumCP↓, Apoptosis↑, P21↑, p27/CDKN1B↑, Casp3↑, Casp9↑, AKT1↓, S6K↓, mTOR↓,
AntiCan↑, TumCP↓, TumCMig↓, FASN↓, FGFR4/CD334↓, PI3K↓, Akt↓,
| - |
vitro+vivo, |
CRC, |
SW480 |
|
|
|
- |
vitro+vivo, |
CRC, |
HCT116 |
|
|
|
AntiCan↑, tumCV↓, Apoptosis↑, TumCCA↑, TumCG↓, PI3K↓, Akt↓, p‑Akt↓, p‑GSK‐3β↓, CDK1↓, NF-kB↓, Bcl-2↓, ERβ/ESR2↑, BAX↑, Bax:Bcl2↑, ROS↑,
AntiCan↑, TumCP↓, TumCI↓, Inflam↓, angioG↓, ROS↑, Apoptosis↑, ChemoSen↑, Risk↓, *antiOx↑, *Inflam↓, *AntiBio↑, *cardioP↑, *neuroP↑, selectivity↑, PUMA↑, Cyt‑c↑, cl‑Casp3↑, cl‑PARP↑, Apoptosis↑, NF-kB↓, COX2/PTGS2↓, CC(CDKs/cyclins)↓, TumCCA↑, BioAv↓, eff↑, DR4↑, DR5↑, Casp3↑, Casp9↑, Casp7↑, TumCP↓, TumCI↓, TumAuto↑, mtDam↑, P53↑, MAPK↑, *lipid-P↓, *TAC↑, *Catalase↑, *SOD↑, *GPx↑, *NRF2↑,
| - |
in-vitro, |
CRC, |
DLD1 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Liver, |
HUH7 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
*antiOx↑, *AntiBio↑, *AntiDiabetic↑, *AntiCan↑, Dose↝, TumCP↓, ER Stress↑, Apoptosis↑, Bcl-2↓, BAX↑, Casp3↑, Casp9↑, Casp12↝, NF-kB↓, P53↑,
AntiCan↑, Dose↝, APG↓,
| - |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
CRC, |
COLO205 |
|
|
|
AntiCan↑, Apoptosis↑, selectivity↑, Ca+2↑, Cyt‑c↑, Casp3↑, Casp8↑, Casp9↑, Bcl-2↓,
| - |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vivo, |
CRC, |
COLO205 |
|
|
|
AntiCan↑, selectivity↑, TumCCA↑, P21↑, Apoptosis↑,
TumCI↓, TumCMig↓, EMT↓, Smad1↓, AntiCan↑, Snail↓, Slug↓, Zeb1↓, ZEB2↓, TGF-β1↓, eff↑, E-cadherin↑, N-cadherin↓, Vim↓,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
SW480 |
|
|
|
- |
in-vitro, |
CRC, |
DLD1 |
|
|
|
β-catenin/ZEB1↓, Wnt↓, TumCP↓, TumCMig↓, *antiOx↑, *Inflam↓, *hepatoP↑, *neuroP↑, *Bacteria↓, *memory↑, AntiCan↑, NF-kB↓, cFos↓, ATF2↓, CREB↓,
Inflam↓, AntiCan↑, Apoptosis↑, MMP↓, P53↑, BAX↑, Casp3↑, Casp9↑, Bcl-2↓, NF-kB↓, IL6↓, IL1β↓, *antiOx↑, *lipid-P↓, *ROS↓, MAPK↓, JAK↓, STAT↓, PI3K↓, Akt↓, chemoP↑, ROS⇅, DNAdam↑, ChemoSen↝,
AntiCan↑, selenoP↓,
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
CRC, |
HT29 |
|
|
|
AntiCan↑, NRF2↓, Prx↓, ChemoSen↑, *Prx↑, *NRF2↑,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
Dose↝, AntiCan↑, eff↑,
Risk↓, Risk↓, Dose∅, AntiCan↑,
| - |
in-vitro, |
Cerv, |
INT-407 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
AntiCan↑, TumCG↓, ROS↑, Apoptosis↑, TumCMig↓, CTNNB1↓, Twist↓, Bcl-2↓, survivin↓, NF-kB↓, Sp1/3/4↓, BAX↑, P21↑, P53↑, eff↓, TumCMig↓,
Showing Research Papers: 1 to 33 of 33
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 33
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
APG↓, 1, FGFR4/CD334↓, 1, HSP60/HSPD1↓, 1, HTRA↓, 1, PSEN2/PS-2↓, 1, TF-Ag↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↓, 1, antiOx↑, 1, lipid-P↑, 1, NRF2↓, 1, NRF2↑, 1, Prx↓, 1, ROS↓, 1, ROS↑, 9, ROS⇅, 1, selenoP↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
ETC↓, 1, MMP↓, 2, MMP↑, 1, mtDam↑, 1, XIAP↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AKT1↓, 1, CREB↓, 1, FASN↓, 1, LDHA↓, 1, PDH↑, 1, S6K↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 5, p‑Akt↓, 2, Apoptosis↑, 19, mt-Apoptosis↑, 1, ATF2↓, 1, BAX↑, 6, Bax:Bcl2↑, 2, Bcl-2↓, 8, Casp↑, 2, Casp12↝, 1, Casp3↑, 7, cl‑Casp3↑, 1, Casp7↑, 1, Casp8↑, 2, Casp9↑, 7, Cyt‑c↑, 4, DR4↑, 1, DR5↑, 1, cl‑GSDME↑, 1, MAPK↓, 2, MAPK↑, 1, p27/CDKN1B↑, 2, PUMA↑, 1, Pyro↑, 1, survivin↓, 3, TumCD↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
AMPKα↑, 1, HCAR2↑, 1, Sp1/3/4↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other↝, 2, tumCV↓, 2,
Protein Folding & ER Stress(tgid=8) ⓘ
ER Stress↑, 1, UPR↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
ATG5↑, 1, Beclin-1/ATG6↑, 1, p62↑, 1, TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 5, p16↑, 1, P53↑, 4, PARP↑, 1, cl‑PARP↑, 1, PCNA↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK1↓, 1, cycD1/CCND1↓, 1, P21↑, 6, TumCCA↓, 1, TumCCA↑, 9,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
cFos↓, 1, CTNNB1↓, 1, EMT↓, 2, ERK↓, 1, p‑GSK‐3β↓, 1, mTOR↓, 2, PI3K↓, 4, PTEN↑, 1, STAT↓, 1, TumCG↓, 7, Wnt↓, 1,
Migration(tgid=13) ⓘ
Ca+2↑, 1, CC(CDKs/cyclins)↓, 1, E-cadherin↑, 2, Ki-67↓, 1, N-cadherin↓, 1, Slug↓, 1, Smad1↓, 1, Snail↓, 1, TGF-β1↓, 1, TumCI↓, 4, TumCMig↓, 5, TumCP↓, 7, Twist↓, 1, Vim↓, 2, Zeb1↓, 1, ZEB2↓, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 3, Endoglin↑, 1, EPR↑, 1, Hif1a↓, 2, VEGF↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
cellSen↑, 1, COX2/PTGS2↓, 1, HCAR2↑, 1, HMGB1↓, 1, IL18↑, 1, IL1β↓, 1, IL6↓, 1, Imm↝, 1, Inflam↓, 3, JAK↓, 1, NF-kB↓, 6,
Hormonal & Nuclear Receptors(tgid=20) ⓘ
ERβ/ESR2↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, BioAv↑, 1, ChemoSen↑, 5, ChemoSen↝, 1, Dose↝, 3, Dose∅, 1, eff↓, 2, eff↑, 9, selectivity↑, 7,
Clinical Biomarkers(tgid=22) ⓘ
GutMicro↑, 1, GutMicro↝, 1, IL6↓, 1, Ki-67↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 33, chemoP↑, 2, chemoPv↑, 2, Risk↓, 3, TumVol↓, 1,
Infection & Microbiome(tgid=24) ⓘ
Bacteria↓, 1,
Total Targets: 139
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
AntiBio↑, 2,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 7, Catalase↑, 1, GPx↑, 1, lipid-P↓, 2, NRF2↑, 2, Prx↑, 1, ROS↓, 3, SOD↑, 1, TAC↑, 1,
Cell Death(tgid=5) ⓘ
JNK↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other↑, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
CHOP/DDIT3↑, 1, cl‑eIF2α↑, 1, GRP78/BiP↑, 1, p‑PERK↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNArepair↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
PI3K↓, 1,
Migration(tgid=13) ⓘ
AP-1↓, 1,
Barriers & Transport(tgid=15) ⓘ
BBB↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↓, 1, Inflam↓, 5, PGE2↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, AntiDiabetic↑, 1, cardioP↑, 2, hepatoP↑, 1, memory↑, 1, neuroP↑, 4, toxicity↓, 3, toxicity↝, 1,
Infection & Microbiome(tgid=24) ⓘ
AntiViral↑, 1, Bacteria↓, 1,
Total Targets: 34
Scientific Paper Hit Count for: AntiCan, Anticancer Effect
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:6 Cells:% prod#:% Target#:813 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page